Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma |
Pathy, Sushmita
(Department of Radiation Oncology, All India Institute of Medical Sciences)
Kumar, Lalit (Department of Medical Oncology, All India Institute of Medical Sciences) Pandey, Ravindra Mohan (Department of Biostatistics, All India Institute of Medical Sciences) Upadhyay, Ashish (Department of Biostatistics, All India Institute of Medical Sciences) Roy, Soumyajit (Department of Radiation Oncology, All India Institute of Medical Sciences) Dadhwal, Vatsla (Department of Obstetrics and Gynecology, All India Institute of Medical Sciences) Madan, Renu (Department of Radiation Oncology, All India Institute of Medical Sciences) Chander, Subhash (Department of Radiation Oncology, All India Institute of Medical Sciences) |
1 | Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ (2003). The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol, 67, 69-76. DOI |
2 | Erridge SC, Kerr GR, Downing D, Duncan W, Price A (2002).The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiother Oncol, 63, 59-66. DOI |
3 | Fyles A, Keane TJ, Barton M, Simm J (1992). The effect of treatment duration in the local control of cervix cancer. Radiother Oncol, 25, 273-9. DOI |
4 | Green JA, Kirwan JM, Tierney JF, et al (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358, 781-6. DOI |
5 | Girinsky T, Rey A, Roche B, Haie C, et al (1993). Overall treatment time in advanced cervical carcinoma: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys, 27, 1051-6. DOI |
6 | Keys HM, Bundy BN, Stehman FB, et al (1999). Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med, 340, 1154-61. DOI |
7 | Krebs L, Maillard S, Gaillot-Petit N, Ortholan C, Nguyen TD (2015). Total radiation dose and overall treatment time are predictive for tumor sterilization in cervical carcinoma treated with chemoradiation and pulsed-dose-rate brachytherapy. Brachytherapy, 14, 16-22. DOI |
8 | Kumaran A, Guruvare S, Sharan K, Rai L, Hebbar S (2014). Chemoradiation related acute morbidity in carcinoma cervix and correlation with hematologic toxicity: a South Indian prospective study. Asian Pac J Cancer Prev, 15, 4483-6. DOI |
9 | Morris M, Eifel PJ, Lu J, et al (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med, 340, 1137-43. DOI |
10 | Perez CA, Grigsby PW, Castro-Vita H, Lockett MA (1995). Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys, 32, 1275-88. DOI |
11 | Peters WA 3rd, Liu PY, Barrett RJ 2nd (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18, 1606-13. DOI |
12 | Rose PG, Bundy BN, Watkins EB, et al (1999).Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 340, 1144-53. DOI |
13 | Song S, Rudra S, Hasselle MD, et al (2013). The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer, 119, 325-31. DOI |
14 | Zamaniah WI, Mastura MY, Phua CE, et al (2014). Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience. Asian Pac J Cancer Prev, 15, 8987-92. DOI |
15 | Viswanathan AN, Thomadsen B (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy, 11, 33-46. DOI ScienceOn |
16 | Whitney CW, Sause W, Bundy BN, et al (1999). Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol, 17, 1339-48. DOI |